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ABSTRACT
Aims To describe the eye misalignments that occur during heroin use and
heroin detoxification and to give an overview of  the management of  persisting
diplopia (double vision) which results from eye misalignment.
Methods A literature review using Medline and the search terms strabismus,
heroin and substance withdrawal syndrome is presented. General management
of  cases presenting to the ophthalmologist and orthoptist with acute acquired
concomitant esotropia is described.
Findings A tendency towards a divergence of  the visual axes appears to be
present in heroin users, although when present it may not always lead to diplo-
pia. Following detoxification intermittent esotropia or constant esotropia (con-
vergence of  the visual axes) can occur; if  intermittent the angle tends to be small
and diplopia present when viewing distance objects. Occlusion of  one eye to
eliminate the second image could encourage the development of  a constant
deviation. The deviation is not caused by a cranial nerve palsy. Constant devi-
ations of  this type are classified as ‘acute acquired concomitant esotropia’. Relief
from the diplopia may be gained by prismatic correction, and the deviation may
then resolve spontaneously. Botulinum toxin or surgical intervention may be
necessary in cases that do not resolve.
Conclusions Heroin use may lead to intermittent or constant exotropia and
withdrawal may result in intermittent or constant esotropia. Awareness of  the
mechanism causing this may avoid referral to other specialties (e.g. neurology)
and awareness of  treatment modalities could encourage patients to seek appro-
priate help for relief  of  symptoms.
KEYWORDS Esotropia, heroin, methadone, strabismus, substance with-
drawal syndrome.
INTRODUCTION
Binocular double vision (diplopia) occurs when there is a
misalignment of  the visual axes of  the two eyes (strabis-
mus). An inward-turning eye leads to esotropia or con-
vergent deviation and an outward-turning eye to an
exotropia or divergent deviation. Ocular deviations can
also result from a palsy of  one or more of  the nerves sup-
plying the extraocular muscles, or a defect of  an extra-
ocular muscle. In such cases, however, the deviation is
incomitant; that is, it varies with direction of  gaze as
opposed to concomitant deviations where the angle is
similar in different directions of  gaze. Table 1 gives a glos-
sary of  terms for easy reference.
Recently double vision, in the absence of  a nerve palsy,
has been reported in the orthoptic and ophthalmological
literature either on the use of, or following detoxification
from, heroin. This article presents a review of  the pub-
lished literature regarding the nature of  changes in ocu-
lar alignment following detoxification, and the small
amount of  evidence that eye alignment may be affected
by the use of  heroin (search terms: strabismus, heroin
and substance withdrawal syndrome). Secondly, the type
of  strabismus which appears to occur on withdrawal from
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heroin is discussed, and finally methods for the treatment
of  double vision that may be undertaken by the orthoptist
or ophthalmologist are considered.
HEROIN USE AND DIPLOPIA
Reported cases of  problems in ocular alignment on the
use of  heroin are rare. Only two cases of  constant exotro-
pia on methadone and/or heroin use have been reported
[1]. In the first heroin was used after the patient had
remained clean for 1 year; double vision occurred hours
after intake. Exotropia was present and resolved within 4
days. The second used heroin and methadone and the
development of  exotropia was dependent on the intake;
this patient had undergone strabismus surgery at the age
of  2 years.
Patients prior to detoxification for heroin/methadone
were compared with a control group of  non-drug users
and found to have larger misalignments at near in the
divergent direction [2]. Although this tendency for diver-
gence could be controlled by many, a tendency for the
misalignment to become apparent was present; double
vision, however, was seldom present, the second image
being ignored.
Cases of  internuclear ophthalmoplegia (INO)
following opiate overdose have been reported [3,4].
Internuclear ophthalmoplegia is seen commonly in
demyelination of, or haemorrhage within, the medial
longitudinal fasciculus. Clinically it presents as loss or
reduction of  adduction (movement of  the eye towards the
nose) on the affected side with nystagmus of  the con-
tralateral abducting eye. The ability to converge the eyes
to keep looking at an approaching target may or may not
be affected. Rizzo & Corbett [5] report one case of  bilateral
INO in a known polydrug user (currently using metha-
done, diazepam, propoxyphene and phenytoin sodium
irregularly for generalized seizures coincident with
the multiple drug use). On presentation there was a
decreased level of  responsiveness; he was complaining
about headaches, blurred vision and lethargy. Naloxone
was administered and within 5 minutes the patient was
alert and eye movements returned to normal. This
response to naloxone is suggestive that the opiate was
responsible for the eye movement defect, although no opi-
ate receptor sites have yet been identified in the region of
the medial longitudinal fasciculus. The bilateral INO
returned about 3 hours later but resolved completely by
day 4.
DIPLOPIA FOLLOWING HEROIN 
DETOXIFICATION
When describing the signs and symptoms of  abrupt with-
drawal from heroin Himmelsbach [6] stated: ‘Occasion-
ally a patient will complain of  double vision. Nearly all
patients, if  they try to read, complain of  some impairment
of  vision.’ The incidence of  ‘diplopia and/or blurred
vision’ during withdrawal among soldiers returning from
Vietnam was reported as between 10% and 33.3%,
depending on the mode of  heroin use [7]; however, no dis-
tinction was made between blurring of  vision and diplo-
pia and no reason for either was given. Since then, little
attention has been given to problems relating to strabis-
mus (Table 2). A single case of  diplopia during heroin
withdrawal appeared to be related to chlorpromazine; the
diplopia resolved 6–8 hours after use and recurred if  chlo-
rpromazine was taken. However, the type of  strabismus is
not given but it is stated that the diplopia was not due to
extra-ocular muscle paresis [8].
Three case series of  diplopia following withdrawal
from heroin have been published recently [1,9,10]. Each
of  these patients (totalling 13) demonstrated an esotropia
Table 1 Glossary of  terms.
Concomitant Angle of  deviation between the eyes is similar in different directions of  gaze
Convergent deviation An inward-turning eye. Used interchangeably with esotropia
Diplopia Double vision
Divergent deviation An outward-turning eye. Used interchangeably with exotropia
Esotropia An inward-turning eye. Used interchangeably with convergent deviation
Exotropia An outward-turning eye. Used interchangeably with divergent deviation
Incomitant Angle of  deviation between the eyes varies with direction of  gaze
Strabismus Misalignment between the eyes
Hypermetropia Long sight
Myopia Short sight
Refractive error Hypermetropia or myopia
Accommodation Focusing of  a near image by change in the intraocular lens
Stereopsis 3D vision from the use of  both eyes
Internuclear ophthalmoplegia Loss/reduction of  adduction of  affected side with nystagmus of  contralateral eye on adduction
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whether looking at near (33 cm) or in the distance (6 m),
commonly of  moderate size (25D-30D), although some-
times smaller. All patients complained of  diplopia. In one
series [10] of  five patients, two had a history of  hyper-
metropia (long-sightedness). Overall six of  the cases
resolved (two with the help of  prisms on glasses in the
interim), one resolved on re-use of  heroin, one was listed
for surgery and in five follow-up was not reported or the
patients were lost to follow-up.
Kowal et al. [10] surveyed 51 doctors on the metha-
done prescriber list in the state of  Victoria, Australia, 22
of  whom treated over 100 patients per year and 29 of
whom treated 25–100 patients per year. Five of  those sur-
veyed prescribed naltrexone. Of  these five one reported
‘about 20 cases’ of  strabismus during detox; one ‘about
10 cases’; blurred vision but no strabismus was reported
by the other. Of  the remaining 46 doctors, only two
reported seeing strabismus, and these were few—four
cases by the first and only one case by the second. This led
to the conclusion that diplopia may be more prevalent in
rapid naltrexone detoxification.
In a prospective study [2], set in a detoxification centre
using a 5-day naltrexone compressed opiate detoxifica-
tion regimen [11], several parameters were assessed on
admission and prior to discharge to determine changes in
the alignment of  the visual axes and control of  any poten-
tial ocular misalignments. A statistically significant
change was found in the angle of  deviation when fixing at
6 m but not at 33 cm. This was also of  clinical signifi-
cance, and led to an intermittent or constant esotropia
with diplopia in 21 of  66 patients. The deviation was not
related to long-sightedness. Measurements of  the mis-
alignments on side gaze, and measurement of  the ability
of  the eyes to maintain single vision when forced diver-
gence was demanded by use of  prisms, showed that this
change in angle was not due to 6th cranial nerve
palsy(ies) or divergence insufficiency (inability of  the eyes
to make a divergence movement). These are conditions
that would usually be considered where the eyes turn in
more for distance than near. This led the authors to sug-
gest that opioid receptors in the brain stem in areas
responsible for maintaining eye alignment may be
responsible. Follow-up was not undertaken but a tele-
phone survey of  eight cases with diplopia at distance
showed that resolution of  diplopia occurred between 2
days and 3 weeks; none sought referral within this period
(unpublished data). It is probable that many cases with
an intermittent problem of  this nature do resolve,
although evidence is not currently available to support
this assumption.
THE MECHANISM FOR DEVELOPMENT 
OF CONSTANT ESOTROPIA
The intermittent nature of  the esotropia reported at
distance (6 m) after heroin withdrawal is similar to
that which may occur in patients with myopia (short-
sightedness) [12]. The deviation may increase progres-
sively in size. A period of  temporary fusional disruption,
i.e. loss of  the eyes being used together because of  the stra-
bismus, may precipitate esotropia or lead to decompensa-
tion of  a pre-existing tendency for misalignment [13,14].
Decompensation is where the control of  the eyes working
together is lost; this may happen intermittently or lead to
a constant deviation. Decompensation may also be pre-
cipitated by the use of  occlusion to get rid of  diplopia [14–
16]. Thus patients suffering diplopia at distance could, by
either of  these mechanisms, develop constant esotropia.
This type of  strabismus is termed ‘acute acquired con-
comitant esotropia’.
Acute acquired concomitant esotropia is an uncom-
mon form of  esotropia, although the following case series
of  this type of  strabismus do appear in the literature,
unrelated to heroin use. Ten cases presented to one
department over a 3.5-year period [17]. Their ages
ranged from 3.5 years to 10 years, with the exception of
one case, who was 24 years old. Most case series reported
are in the childhood age bracket [18–21]. However, a few
cases are to be found in the adult age group (two cases
[22] and one case [23]). One series of  10 cases over the
age of  16 years is reported, presenting over a 7-year
period [24]. Long-sightedness was present in some
patients and its correction was sufficient to control the
deviation [15,23]. Conversely, short-sightedness may be
present [24]. The onset of  this type of  strabismus can
be related to neurological disease [25], but further
investigation is not usually undertaken unless there are
Author (year of  publication) Research design No. of  participants
Ream et al. (1975) [7] Observational 496
Iqbal (2000) [8] Case report 1
Firth (2001) [9] Case series 3
Kowal et al. (2003) [10] Case series 5
Sutter & Landau (2003) [1] Case series 5
Firth et al. (2004) [2] Prospective, repeated-measures
design
69
Table 2 Literature pertaining to diplo-
pia on withdrawal from heroin.
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accompanying neurological signs. Thus acute acquired
concomitant esotropia is even less common in the adult
population than during childhood.
MANAGEMENT OF ACUTE ACQUIRED 
CONCOMITANT ESOTROPIA
Where acquired esotropia presents the first stage of  man-
agement is to correct any refractive error present. Correc-
tion of  long-sight may help the deviation as it removes
excessive effort of  focusing and thus reduces the associ-
ated convergence. Patients who present with a late-onset
form of  esotropia have developed the ability to use their
eyes together and have stereopsis prior to the onset of  the
strabismus, hence the aim of  treatment is to restore the
correct eye alignment. Prismatic correction by the use of
Fresnel prisms (plastic film composed of  prisms) placed
onto spectacles enables the two images to be joined and
restores the use of  the two eyes correctly. This may be as a
temporary measure prior to surgical correction [21], but
can lead to resolution of  the deviation. This occurs as the
patient regains the use of  the two eyes correctly and the
prism strength can then be gradually reduced [16]. Two
cases of  esotropia reported following heroin detoxifica-
tion were controlled in this way [9,10].
While many cases with acquired esotropia require
strabismus surgery [17,21,24], an alternative is an
injection of  botulinum toxin into the medial rectus
[21,22,26]. This temporarily paralyses the medial rectus,
causing a reduction in the esotropia or even divergence of
the eyes. Once fusion is restored it is usually maintained
as the effect of  the botulinum toxin gradually wears off.
CONCLUSIONS
Esotropia may occur after detoxification from heroin. The
diplopia that this causes is a disturbing symptom, but is
treatable by prismatic correction in the short term, botu-
linum injection and strabismus surgery in the longer
term if  the esotropia persists. Occlusion of  one eye should
be avoided as this may encourage decompensation to a
constant deviation. Where the esotropia is constant or
persists as an intermittent problem, patients should be
referred for an orthoptic opinion. Changes in ocular
alignment can also occur on use of  heroin and very occa-
sionally this may lead to diplopia.
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